The chart below shows how ALGN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ALGN sees a +1.27% change in stock price 10 days leading up to the earnings, and a -5.16% change 10 days following the report. On the earnings day itself, the stock moves by +0.37%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Q4 Revenue Increase: Q4 total revenues reached $995 million, marking a 4% year-over-year increase, driven by a 14.9% growth in Systems and Services revenues and a 1.6% growth in Clear Aligner revenues.
Clear Aligner Volume Growth: Clear Aligner volumes grew 6.1% year-over-year in Q4, with significant increases in shipments across EMEA, APAC, and LatAm regions, indicating strong demand and market penetration.
Revenue and Volume Growth: For the full year 2024, total revenues reached $4 billion, with Clear Aligner volumes totaling 2.5 million cases, both reflecting a 3.5% year-over-year growth.
Invisalign Practitioner and Patient Growth: The number of active Invisalign trained practitioners reached 272,000, and the total number of Invisalign patients treated increased to 19.5 million, showcasing strong customer growth and engagement.
Ancillary Services Growth: Q4 non-case revenues increased significantly, with total Doctor Subscription Program touch-up cases up nearly 37% year-over-year, indicating robust growth in ancillary services.
Negative
Clear Aligner ASP Decline: Q4 Clear Aligner ASPs were lower than expected, primarily due to unfavorable foreign exchange, resulting in a $10 decrease per case shipment sequentially and a $55 decrease year-over-year.
Rising Operating Expenses: Operating expenses for Q4 increased by 11% year-over-year to $552.8 million, driven by higher restructuring, advertising, and marketing expenses, indicating rising cost pressures.
Operating Income Decline: Q4 operating income of $144.1 million led to an operating margin of 14.5%, down 2.1 points sequentially and down 3.4 points year-over-year, reflecting declining profitability.
Interest Income Decline: Interest and other income for Q4 was a net expense of $3.4 million, a significant decline from income of $3.6 million in Q3 2024, primarily due to unfavorable foreign exchange movements.
Q1 2025 Revenue Decline: Q1 2025 revenue guidance is projected to decline sequentially to between $965 million and $985 million, primarily due to lower capital equipment sales and unfavorable foreign exchange impacts.
Align Technology, Inc. (NASDAQ:ALGN) Q4 2024 Earnings Call Transcript
ALGN.O
-3.85%